4.49
price up icon7.16%   0.30
after-market Dopo l'orario di chiusura: 4.50 0.010 +0.22%
loading
Precedente Chiudi:
$4.19
Aprire:
$4.12
Volume 24 ore:
1.46M
Relative Volume:
0.80
Capitalizzazione di mercato:
$713.72M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
-0.7434
EPS:
-6.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
+5.65%
1M Prestazione:
+4.42%
6M Prestazione:
-44.70%
1 anno Prestazione:
-52.74%
Intervallo 1D:
Value
$4.06
$4.51
Intervallo di 1 settimana:
Value
$3.93
$4.51
Portata 52W:
Value
$3.79
$15.70

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Nome
Ironwood Pharmaceuticals Inc
Name
Telefono
617-621-7722
Name
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Dipendente
267
Name
Cinguettio
@ironwoodpharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IRWD's Discussions on Twitter

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-01-17 Iniziato Craig Hallum Buy
2023-12-14 Iniziato Wells Fargo Overweight
2023-11-09 Iniziato Jefferies Buy
2023-09-28 Iniziato JMP Securities Mkt Outperform
2022-09-02 Iniziato CapitalOne Overweight
2022-04-22 Iniziato Piper Sandler Overweight
2020-09-30 Downgrade Wells Fargo Overweight → Equal Weight
2020-06-17 Iniziato Northland Capital Outperform
2019-07-10 Ripresa Credit Suisse Neutral
2019-03-27 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-02-25 Aggiornamento H.C. Wainwright Sell → Neutral
2019-01-24 Aggiornamento JP Morgan Underweight → Neutral
2018-11-07 Downgrade Credit Suisse Outperform → Neutral
2018-11-07 Downgrade JP Morgan Neutral → Underweight
2018-07-23 Iniziato H.C. Wainwright Sell
2018-05-09 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-01-05 Downgrade BofA/Merrill Buy → Underperform
2017-12-06 Downgrade Mizuho Buy → Neutral
2017-07-21 Downgrade JP Morgan Overweight → Neutral
2017-05-03 Iniziato Wells Fargo Outperform
2017-04-07 Reiterato Mizuho Buy
2017-02-22 Reiterato Barclays Equal Weight
2016-11-04 Reiterato Mizuho Buy
2016-10-24 Reiterato Wedbush Neutral
2016-10-10 Reiterato Mizuho Buy
2016-09-27 Reiterato WallachBeth Hold
Mostra tutto

Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie

pulisher
02:25 AM

Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com

02:25 AM
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Emerald Mutual Fund Advisers Trust Sells 446,757 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine

Oct 31, 2024
pulisher
Oct 31, 2024

Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 28, 2024

Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR

Oct 28, 2024
pulisher
Oct 28, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Ironwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease Study - MarketWatch

Oct 28, 2024
pulisher
Oct 28, 2024

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2 - Business Wire

Oct 28, 2024
pulisher
Oct 27, 2024

Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World

Oct 27, 2024
pulisher
Oct 24, 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - Business Wire

Oct 24, 2024
pulisher
Oct 24, 2024

Lacklustre Performance Is Driving Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Low P/S - Simply Wall St

Oct 24, 2024
pulisher
Oct 21, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8%What's Next? - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Exchange Traded Concepts LLC Takes Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 21, 2024
pulisher
Oct 19, 2024

Financial Survey: Regulus Therapeutics (NASDAQ:RGLS) & Ironwood Pharmaceuticals (NASDAQ:IRWD) - Defense World

Oct 19, 2024
pulisher
Oct 18, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Zacks Research Has Negative Outlook for IRWD FY2025 Earnings - Defense World

Oct 18, 2024
pulisher
Oct 17, 2024

Zacks Research Research Analysts Decrease Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

Zacks Research Analysts Lower Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 17, 2024
pulisher
Oct 17, 2024

Wedge Capital Management L L P NC Purchases Shares of 314,843 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

The Manufacturers Life Insurance Company Trims Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts? - Insider Monkey

Oct 16, 2024
pulisher
Oct 16, 2024

Q1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by Analyst - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.1%What's Next? - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Leerink Partners gives a Market perform recommendation for Ironwood Pharmaceuticals Inc (IRWD) - Knox Daily

Oct 15, 2024
pulisher
Oct 14, 2024

Financial Metrics Exploration: Understanding Ironwood Pharmaceuticals Inc (IRWD) Through Ratios - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

Ironwood Pharmaceuticals Inc (IRWD) did well last session? - US Post News

Oct 14, 2024
pulisher
Oct 12, 2024

14,200 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Algert Global LLC - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Irritable Bowel Syndrome Treatment Market is Booming with - openPR

Oct 11, 2024
pulisher
Oct 11, 2024

Insider Selling: John Minardo, Ironwood Pharmaceuticals Inc [IRWD] Chief Legal Officer divested 9,910 shares - Knox Daily

Oct 11, 2024
pulisher
Oct 10, 2024

How to interpret Ironwood Pharmaceuticals Inc (IRWD)’s stock chart patterns - US Post News

Oct 10, 2024
pulisher
Oct 09, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... By GuruFocus - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 3.6% HigherShould You Buy? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Bank of Montreal Can Sells 8,419,683 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Ratio Analysis: Unpacking Ironwood Pharmaceuticals Inc (IRWD)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Taking a Closer Look At Ironwood Pharmaceuticals Inc (IRWD) Following Its Recent Trade - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

8 Penny Stocks with Biggest Upside Potential According to Analysts - Insider Monkey

Oct 08, 2024
pulisher
Oct 08, 2024

Squarepoint Ops LLC Has $688,000 Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 08, 2024
pulisher
Oct 07, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 6.7%Should You Sell? - MarketBeat

Oct 07, 2024
pulisher
Oct 07, 2024

An analyst sees good growth prospects for Ironwood Pharmaceuticals Inc (IRWD) - SETE News

Oct 07, 2024
pulisher
Oct 06, 2024

Marshall Wace LLP Has $1.42 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 06, 2024
pulisher
Oct 04, 2024

American Century Companies Inc. Trims Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

American Century Companies Inc. Cuts Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Axa S.A. Decreases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Ironwood Pharmaceuticals Inc (IRWD) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 03, 2024
pulisher
Oct 02, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6% - Defense World

Oct 02, 2024
pulisher
Oct 02, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 6% Higher - MarketBeat

Oct 02, 2024

Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Silver Ronald
Principal Accounting Officer
Aug 12 '24
Sale
4.27
3,107
13,267
158,370
$12.67
price up icon 0.88%
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Capitalizzazione:     |  Volume (24 ore):